News

Check out the latest news about Evidity Health Capital and our portfolio companies.

header-news-1278x1024
  • All
  • 2021
  • 2022
  • 2023
  • 2025

GT Medical Technologies Raises $37 Million in Series D to Advance the Expansion of GammaTile® in the U.S. for Patients with Operable Brain Tumors

Evidity Health Capital’s Adam Lessler, MD named Partner

Augmedics raises $82.5 million to accelerate adoption of augmented reality spine surgery

Sonde Health Raises $19.25 Million Series B to Build the Next Generation of Voice-Based Health Monitoring

BD, Magnolia Medical Technologies Announce Commercial Collaboration to Help Reduce Blood Culture Contamination and Improve Testing Accuracy

Digital Medicine Leader Akili to List on Nasdaq Following Successful Business Combination with Social Capital Suvretta Holdings Corp. I

EndoGastric Solutions, Inc.® Announces TIF® Procedure Included in New American Gastroenterology Association (AGA) Clinical Practice Update and American College of Gastroenterology (ACG) Guideline

Magnolia Medical Technologies Wins Patent-Infringement Lawsuit against Kurin, Inc.

AcuFocus Announces FDA Approval for the IC-8® Apthera™ Intraocular Lens, the First and Only Small Aperture Lens for Cataract Surgery

PreludeDxTM Closes $20 Million in Funding to Advance Growth Initiatives and Development of Its Precision Medicine Portfolio

Akili Interactive, a Leader in Digital Medicine, to Become Publicly Traded Through Combination with Social Capital Suvretta Holdings Corp. I

Akili Secures $160 Million in Financing; Poised to Deliver on the Promise of Digital Therapeutics

Haemonetics To Acquire Cardiva Medical, Inc. To Expand Hospital Portfolio

Biotheranostics Announces Inclusion of Breast Cancer Index™ in the National Comprehensive Cancer Network (NCCN) Breast Cancer Guidelines for Prediction of Benefit from Extended Endocrine Therapy

Hologic to Acquire Biotheranostics, Leader in Molecular Tests for Breast and Metastatic Cancers, for Approximately $230 Million